State of Wyoming Takes $1. 76 Million Position in Elevance Health, Inc. $ELV
State of Wyoming purchased a new stake in Elevance Health, Inc. (NYSE:ELV - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 4,564 shares of the company's stock, valued at approximately $1,765,000. A number of oth
State of Wyoming purchased a new stake in Elevance Health, Inc. (NYSE:ELV-Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 4,564 shares of the company's stock, valued at approximately $1,765,000. GetElevance Healthalerts:UnitedHealth Just Gave Wall Street a Clearer Turnaround SignalA number of other large investors have also added to or reduced their stakes in the stock. WealthCollab LLC raised its holdings in Elevance Health by 42. 2% in the 1st quarter. WealthCollab LLC now owns 91 shares of the company's stock valued at $27,000 after acquiring an additional 27 shares in the last quarter. Signet Financial Management LLC grew its holdings in shares of Elevance Health by 3. 5% during the 1st quarter. Signet Financial Management LLC now owns 837 shares of the company's stock worth $245,000 after purchasing an additional 28 shares in the last quarter. Sapient Capital LLC grew its holdings in shares of Elevance Health by 1. 2% during the 1st quarter. Sapient Capital LLC now owns 2,612 shares of the company's stock worth $765,000 after purchasing an additional 31 shares in the last quarter. Mutual Advisors LLC increased its position in shares of Elevance Health by 1. 4% in the fourth quarter. Mutual Advisors LLC now owns 2,290 shares of the company's stock worth $803,000 after purchasing an additional 32 shares during the period. Finally, Waddell & Associates LLC increased its position in shares of Elevance Health by 2. 6% in the fourth quarter. Waddell & Associates LLC now owns 1,241 shares of the company's stock worth $435,000 after purchasing an additional 32 shares during the period. Institutional investors and hedge funds own 89. 24% of the company's stock. Elevance Health Trading Up 0. 6%ELVopened at $400. 63 on Friday. The company has a market cap of $86. 88 billion, a P/E ratio of 17. 81, a PEG ratio of 2. 30 and a beta of 0. 68. The company has a current ratio of 1. 52, a quick ratio of 1. 52 and a debt-to-equity ratio of 0. 68. The company's 50 day moving average is $396. 05 and its 200-day moving average is $358. 15. Elevance Health, Inc. has a 1-year low of $274. 84 and a 1-year high of $436. 24. This ETF Is Proof That the Healthcare Rebound Is RealElevance Health (NYSE:ELV-Get Free Report) last released its quarterly earnings data on Wednesday, July 15th. The company reported $7. 45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6. 21 by $1. 24. The business had revenue of $49. 83 billion during the quarter, compared to analysts' expectations of $48. 88 billion. Elevance Health had a net margin of 2. 47% and a return on equity of 14. 64%. The firm's quarterly revenue was up . 8% compared to the same quarter last year. During the same period in the prior year, the company earned $8. 84 EPS. Equities research analysts predict that Elevance Health, Inc. will post 27. 07 earnings per share for the current fiscal year. Elevance Health Announces DividendThe business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Thursday, September 10th will be issued a dividend of $1. 72 per share. The ex-dividend date is Thursday, September 10th. This represents a $6. 88 annualized dividend and a dividend yield of 1. 7%. Elevance Health's dividend payout ratio is 30. 58%. Analysts Set New Price TargetsGetting Defensive: 3 Dividend Payers Reporting Strong Q3 EarningsELV has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft raised shares of Elevance Health from a "hold" rating to a "buy" rating and upped their price objective for the stock from $363. 00 to $498. 00 in a research report on Wednesday, May 20th. Robert W. Baird raised their target price on shares of Elevance Health from $331. 00 to $393. 00 and gave the company a "neutral" rating in a report on Thursday, July 16th. Evercore restated a "hold" rating on shares of Elevance Health in a research report on Tuesday, May 19th. Barclays cut their price target on shares of Elevance Health from $480. 00 to $457. 00 and set an "overweight" rating for the company in a report on Thursday, July 16th. Finally, TD Cowen lifted their price objective on shares of Elevance Health from $400. 00 to $465. 00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Fifteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat. com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $440. 90. View Our Latest Stock Analysis on ELVInsider Activity at Elevance HealthIn other news, DirectorRobert L. Dixon, Jr. sold 151 shares of the stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $401. 77, for a total value of $60,667. 27. Following the completion of the transaction, the director directly owned 10,734 shares in the company, valued at approximately $4,312,599. 18. This represents a 1. 39% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible throughthis hyperlink. Insiders own 0. 34% of the company's stock. About Elevance Health(Free Report)Elevance Health,IncNYSE: ELVis a large U. S. -based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery. Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products. Further ReadingFive stocks we like better than Elevance HealthIs Best Buy the AI Winner Hiding in the Electronics Aisle?Applied Materials Beat Everything but Wall Street’s Expectations for MarginsBack From Orbit, Intuitive Machines' Share Price Enters the Buy ZoneTexas Roadhouse and Brinker International Have the Recipe Rivals Are MissingWant to see what other hedge funds are holding ELV?Visit HoldingsChannel. comto get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV-Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Continue following MarketBeatAdd MarketBeat as your preferred source on Google to see our latest stories in your feed. Should You Invest $1,000 in Elevance Health Right Now?Before you consider Elevance Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Elevance Health wasn't on the list. While Elevance Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public. Get This Free Report